Examines Office-Based Transperineal Prostate Biopsies Methodology.

Published Date: 04 Mar 2024

In a randomized trial, the antibiotic-free option produced zero infections.

Read Full News

Latest News

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Todays Updates

Abnormal Shadow on Chest Radiograph

Culture findings were key in making the diagnosis

Did Breast Cancer Radiation Cause This Weird Lung Problem?

Especially peculiar since the patient had no risk factors

Todays Updates

Abnormal Shadow on Chest Radiograph

Culture findings were key in making the diagnosis

Did Breast Cancer Radiation Cause This Weird Lung Problem?

Especially peculiar since the patient had no risk factors

Latest News

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

News, features, and commentary about cancer-related issues

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

News, features, and commentary about cancer-related issues

News All Time

Early Sugar Exposure and Cancer Risk; Melanoma Vaccine Win; 'Antifreeze' for CAR-T

News, features, and commentary about cancer-related issues

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Cognitive Bias Modification App Fosters Alcohol Avoidance

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Recommended News For You

FDA Panel Endorses Capivasertib Use in Prostate Cancer

High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

Similar survival seen with simple versus radical hysterectomy for cervical cancer

Waiting for a Sharp Increase in Prostate Cancer Cases.

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.

Recommended Articles For You

Clinical Guidelines for Hematopoietic Stem Cell Niche Monitoring in Blood Disorders 

Breaking Barriers: Innovative Approaches in Brain Tumor Treatment 

Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment 

Innate Lymphoid Cells in Tumor Biology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

2.

ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death

3.

Are patients with advanced cancer receiving treatment aligned with their goals?

4.

PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.

5.

No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC

1.

Red Cell Adaptation During Female Reproductive Transitions: Mechanisms, Clinical Implications, and Evidence-Based Insights

2.

Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL

3.

Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology

4.

Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management

5.

The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Scenario of Cancer- The Incidence of Cancer in Men

2.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

3.

Navigating the Complexities of Ph Negative ALL - Part I

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot